Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9540 clinical trials
featured
A Study to Evaluate the Safety Tolerability and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease

Parkinson's Disease (PD). The secondary objective of this study is to evaluate the pharmacokinetic (PK) profile of BIIB094.The study is open for PD patients with verified presence or absence of mutations in the

dyskinesia
  • 250 views
  • 17 Nov, 2020
  • 14 locations
featured
A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations

urinary tract cancer
  • 1062 views
  • 08 Dec, 2020
  • 62 locations
featured
Advanced Breast Cancer with Visceral Metastases

People with advanced breast cancer are asked to participate in a research study being conducted by White Plains Hospital.  

advanced breast cancer
  • 22 views
  • 02 Aug, 2019
  • 1 location
featured
Phase II/III Study of Image-Guided Radiosurgery/SBRT For Localized Spine Metastasis

Phase II/III Study of Image-Guided Radiosurgery/SBRT For Localized Spine Metastasis

metastatic cancer
  • 14 views
  • 03 Dec, 2020
  • 1 location
featured
Pediatric Hyperparathyroidism & Chronic Kidney Disease

Children with Secondary Hyperparathyroidism & Chronic Kidney Disease are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.  

  • 57 views
  • 18 Jan, 2019
  • 1 location
featured
An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis

This is a randomized, open label, parallel, active comparator study in patients aged 5– 18 years with Chronic Kidney Disease (CKD) Stages 3 and 4 and secondary hyperparathyroidism (SHPT) not

  • 45 views
  • 11 Jun, 2020
  • 1 location
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients with Generalized Myasthenia Gravis IND 140,115 STUDY NUMBER: ALXN1210-MG-306

-ADL) profile. Secondary To assess the efficacy of ravulizumab compared with placebo in the treatment of gMG based on the improvement in the Quantitative Myasthenia Gravis

myasthenia gravis
edrophonium chloride test
methotrexate
cyclophosphamide
acetylcholinesterase inhibitors
  • 187 views
  • 24 Nov, 2020
  • 1 location
featured
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction

participants with Large Hemispheric Infarction (LHI). The secondary objectives are to determine if BIIB093 improves overall survival at Day 90 when compared with placebo, if BIIB093

  • 12 views
  • 12 Aug, 2020
  • 1 location
featured
A PHASE 3 TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

treatment withdrawal period. - To assess safety and tolerability. Key Secondary:

  • 63 views
  • 23 Nov, 2020
  • 2 locations
featured
AnaLysIs of Both Sex and Device Specific FactoRs on Outcomes in PAtients with Non-Ischemic Cardiomyopathy - Bio Libra

Secondary Objectives All-cause mortality, VT or VF alone, risk of cardiac death, and sudden cardiac death for the total cohort, as well as by sex and by the implanted

sudden cardiac death
ejection fraction
shock
  • 48 views
  • 24 Nov, 2020
  • 1 location